Clinical chemistry hormone IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
23-10-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Ortho-Clinical Diagnostics Australia Pty Ltd
Class:
Class 2
Manufactured by:
Diagnostic Hybrids Inc also trading as Quidel Corporation 2005 East State Street Suite 100, Athens, OH, 45701 United States Of America
Therapeutic area:
CT850 - Clinical chemistry hormone IVDs
Therapeutic indications:
IVDs that are intended to be used for the qualitative and/or quantitative determination of clinical chemistry hormones, Thyretain TSI and TBI, in a clinical specimen.
Authorization status:
A
Authorization date:
2020-10-01
